In the fourth quarter of this fiscal year, we are launching our online promotional campaigns, including paid search, programmatic displays, and social media advertising to drive awareness and incremental adoption and should result in an increase in overall sales and marketing spend by $1 to $2 million, depending on their breadth and overall impact. Additionally, we have increased our speaker program events spending, medical education content, and conferences involvement, which will likely increase our G&A spending by $200,000 to $300,000 in the upcoming quarter.

May 13, 2026 / receipt

In the fourth quarter of this fiscal year, we are launching our online promotional campaigns, including paid search, programmatic displays, and social media advertising to drive awareness and incremental adoption and should result in an increase in overall sales and marketing spend by $1 to $2 million, depending on their breadth and overall impact. Additionally, we have increased our speaker program events spending, medical education content, and conferences involvement, which will likely increase our G&A spending by $200,000 to $300,000 in the upcoming quarter.

May 13, 2026 / receipt, needs a key / Ryan, CFO | earnings call 2026-05-13 | transcript 02375139-78b4-4a5c-a01e-bba027cee4ff | chars 26018-26586 | segment 26

I've traveled with a couple of our top sales specialists visiting with doctors in Texas as we began the process of presenting Exua to the market.

Sep 23, 2025 / receipt, needs a key / Josh, CEO | earnings call 2025-09-23 | transcript 623fd0e7-e1f7-4afc-84c6-e69191a98f5a | chars 29943-30088 | segment 30

The decreases were a result of reductions in marketing expenses, such as general promotional costs, as well as shifts in marketing and market access, reducing costs by $900,000, reductions in the cost of contracted services and other professional fees in the amount of $600,000, and finally, headcount reductions and associated travel costs, reducing expenses by $400,000.

Nov 13, 2024 / receipt, needs a key / Ryan Selhorn, CFO | earnings call 2024-11-13 | transcript 576dce7f-8861-4894-808d-d5a0d1e1fa5f | chars 17902-18274 | segment 18

And so, you know, a lot of it just depends on which day they orders and what have you. But there were some delays because of the travel, both products that were in transit and the timing of when they left our docks. So that all got arrived in the next week.

Feb 21, 2023 / receipt, needs a key / Josh, CEO | earnings call 2023-02-21 | transcript 194d4877-0970-4e6b-85f8-2f9e5dca601c | chars 29234-29491 | segment 29

Broad Aytu RxConnect footprint for enhanced patient access, adoption, & adherence

ir_statement / Sep 13, 2026 / receipt

Efficient, multi-faceted launch with emphasis on sales force promotion and metrics-based performance management

ir_statement / Sep 13, 2026 / receipt

Full retail distribution to achieve broad-based availability

ir_statement / Sep 13, 2026 / receipt

New Chemical Entity (NCE) education led by cost-effective Medical Affairs-led publication and KOL support

ir_statement / Sep 13, 2026 / receipt

EXXUA for MDD recently launched and set to be significant contributor to net revenue

ir_statement / Sep 13, 2026 / receipt

Planned investments in EXXUA launch

ir_statement / Sep 13, 2026 / receipt

Production outsourcing & operational improvements have driven gross margin improvement

ir_statement / Sep 13, 2026 / receipt

Aytu RxConnect® is a proprietary, best-in-class patient access program, supported by an efficient commercial infrastructure, to support patient access to Aytu Rx products.

ir_statement / Sep 13, 2026 / receipt

Focused Specialty Sales Force

ir_statement / Sep 13, 2026 / receipt

Over 1,000 pharmacies nationwide with 100% sales territory coverage; fully supported by in-house pharmacy support team

ir_statement / Sep 13, 2026 / receipt

Efficient, experienced, and leverageable commercial infrastructure for Rx Portfolio through initial 40 territories allows for rapid scalable promotional expansion opportunities

ir_statement / Sep 13, 2026 / receipt

Further support enabled through in-house analytics platform, virtual/tele-sales and select, efficient direct-to-patient initiatives

ir_statement / Sep 13, 2026 / receipt